![]() |
Acomplia - now THIS sounds interesting!!
Now everyone knows I'm a COMPLETE skeptic, but ya know I'll be watching how THIS develops:
Quote:
|
I saw that on the news yesterday!! I'm curious to hear more about it once it is actually out on the market.
|
Well, think logically about that, if you are taking the pill to help lose weight, odds are your subconcious is going to kick in and you are going to be doing things you wouldn't normally do to:
A: Make the process go even faster and B: Keep the weight off. Kind of like when you get something new and kind of expensive, you coddle it for a while so it won't get broken without even realizing it. Many people do this, it's normal. Odds are while you're taking the drug, you're lifestyle would change to the point that if you went off the pill and gained a few pounds, it wouldn't matter, because with your new lifestyle you'd lose them again anyway. The reason they gained weight after going off the pill was probably because this was a controlled study, and they told the participants not to do anything out of the ordinary (AKA: eat differently or exercise more than they were doing). |
Quote:
Note that the people that gained weight after going off the pill in the second year were on a placebo - they didn't know that they were off the pill. Additionally, all participants were on a reduced-calorie diet throughout the study. Quote:
|
As much as I think some day there will be a miracle pill, it makes you wonder. Look at all of these drugs and what they do to people. I love listening to these commercials and wondering why people even bother. Eye drops for dry eyes that can cause temporary blindness and burning. A feminine product that can cause dementia and heart attack. Heck, just look at what the research is saying high fructose corn syrup does to us. (Maybe I should cut back on the splenda!)
I guess my point is even though it takes a lot of work, I'd rather watch what I eat and exercise than take a pill which will lower heath risks of being overweight only to cause a side effect of paralysis or something. |
Quote:
The spectre of Phen-Fen is always in the background...IMO, as previously stated, I believe that the pharmecutical industry learnt a valuable (and costly) lesson from that experience and will be VERY careful about both short-term and long-term safety. But I already take a BCP and a multivitamin every day anyway. I know quite a few people on daily meds - HRT, blood pressure, heart meds, etc. To be able to take a daily medication to allieviate those killer cravings...I wouldn't have a problem with that whatsoever, as long as it's SAFE AND EFFECTIVE. We'll see what happens... |
This is all very interesting. I have read very little about this drug but it does show some promises. I am so afraid of medications now I doubt I would take it. I took Celebrex and now you read all this terrible stuff about it. And the weight gain was terrible. Who knew? It would be so nice to have a pill to take but realistically I'm sticking to my calorie counting. :^:
|
I think the best thing to do it stay away from drugs to loss weight. I took phen-fen when i was 15 years old. By the time i was 17 teen i started passing out. My heart was damaged and know ever six months i have to have my heart checked to make sure theres no bleeding. I still pass out time to time. Dr. still try to give me diet pills but i want take any to scared.
|
Hi there. Just thought I'd drop a note on this subject. My best friend was/is actually doing the testing for this drug. She works for Sanofi in Pennsylvania. From what she says and has seen, it works. It should become available in or around May 2005. They've had extremely successful results with this drug and are very excited to be offering it soon. If I hear more from her, I'll post again and give an update. All I know is that I'll be buying some stocks in Sanofi soon. Lol. :lol:
|
Quote:
However...3 months sounds a bit soon for a prescription drug to be put on the market. The most recent information I could find says that Sanofi is still doing clinical trials on the drug - doesn't look like it's even gotten to the FDA yet. And with the recent news regarding other prescription drugs such as Vioxx and in the past with Redux and fenfluramine, I'm sure that the FDA will be very, VERY careful in reviewing Acomplia. Perhaps you meant 2006? |
Quote:
* The HUGE increase in weight loss surgeries - which is supposed to be utilized as a last resort after everything else (regular diet and exercise) has failed, to me is a PRIME reason to be looking for other medical alternatives. Often it is not covered by insurance (and more and more carriers or employers are declining to cover the surgery) and it's a fairly risky procedure, with a very high price tag. IMO having a viable pharmecutical alternative to WLS would definitely be a plus. * I remember back in the 1970's & 80's there were TONS of 'miracle hair restorer' products on the market...maybe as many or MORE than there were 'miracle weight loss' products. Then in 1988, Rogaine became the first pharmaceutical ever approved by the US Food and Drug Administration as being safe and effective for hair growth (followed in 1998 by Propecia) and the VAST majority of those 'miracle hair cures' went POOF. I can easily see that happening in the event that a truly safe and effective weight loss medication (I would rather not use the term "Magic pill") is found. If Acomplia turns out to be 'what the doctor ordered'...IMO that would be a fatal, or near-fatal, blow to many of the weight loss snake-oil hucksters out there. (BTW I can't resist adding that when I typed the bit about hair loss, I couldn't help but visualize that Seinfeld episode where George orders the stinky hair growth potion from China... :lol: ) And if it helps smokers quit - there's ANOTHER bonus. :) Of course bottom line it comes down to 'calories in calories out'/'eat less move more' - but there are MANY people who need help - I suppose, like WLS, you would call it a 'tool'. |
I work in a large med. school where the Pharm. Reps. round constantly. The next time I see the Sanofi-Aventis rep. I'll ask her for some info. on approval. marketing dates. This may become popular from a cardiovascular point of view. Since Sanofi bought out Aventis I haven't seen too many of the old pharmaceutical reps, they usually shift things around.
what caught my eye was the line about "reduction in weight circumference" (I'll beg for samples of the drug if that is true!) In my area, on one of the local cable stations, one of the bariatric surgeons actually has an infomercial...... |
We've all seen what can happen to a drug touted as the miracle answer, whether it's for weightloss, arthritis, diabetes, etc. Researchers find something that truly does work, but they can't know the safety record until millions of people have volunteered to be guinea pigs for them.
All drugs are poison, in some form or another. Each of us reacts differently to the poison--some of us would take Vioxx today if we could get our hands on it, because it did NOT cause us health problems. But it was deadly for others, and we only found out too late. I'd love to think that modern medicine could come up with an appetite suppressant that wouldn't have side effects. But when this drug comes out, I will not be among its first users, no matter how tempted I am. I will wait at least a year to see if it's truly safe. Even then, I always opt for the lowest possible dosage of any drug, because one year of public testing isn't always enough. |
New Article on Acomplia.
Experimental Diet Pill Keeping Pounds Off By MARILYNN MARCHIONE ORLANDO, Fla. (AP) - A second study confirms that an experimental diet pill can help people lose weight and keep it off for up to two years, setting the stage for its maker to seek approval to sell it in the United States. The drug, rimonabant, which the French company Sanofi-Aventis hopes to sell under the brand name Acomplia, trimmed nearly 16 pounds on average from people taking the optimal dose for two years, compared with 5.5 pounds for those who took dummy pills, doctors reported Tuesday at a cardiology conference. ``The majority of the weight that was lost at one year is still maintained after two years. There is only a slight increase over that second year,'' said Dr. Luc Van Gaal of University Hospital in Antwerp, Belgium, who led the company-funded study involving 1,507 severely obese people in Europe. About two-thirds of American adults are overweight or obese; in European countries, one-third to half are. Diet drugs sold now are only for short-term use or have unpleasant side effects that make it tough to stay on them. Acomplia works in an entirely different way, by blocking a ``pleasure center'' in the brain, leading people to eat less and acting directly on fat cells to prevent weight gain. Company studies suggest it also might help people quit smoking. In a North American study of 3,040 obese people reported last fall, those given the higher of two doses of the drug lost about 19 pounds and kept it off for up to two years, compared with only 5 pounds for those given fake pills. In the new study, those on the higher dose regained some weight in the second year but fared far better than those on placebo. Waistlines in the drug group were 3.4 inches smaller after one year and 3 inches after two. The proportion of people with metabolic syndrome - a collection of unhealthy conditions such as high blood sugar and blood pressure and low amounts of ``good'' cholesterol - went from 42 percent at the start of the study to 21 percent at two years for those on the higher dose of the drug. Dr. Sidney C. Smith, a former American Heart Association president and cardiology chief at the University of North Carolina, said this was especially important, since 47 million Americans have metabolic syndrome. However, the drug has side effects: 13.7 percent on the optimal dose reported nausea compared with 5.5 percent taking dummy pills, though researchers said it tended to be mild and short-lived. Rates of dizziness and diarrhea were almost twice as common on the drug. About 19 percent on the higher dose dropped out of the study because a problem occurred, but so did 13 percent in the placebo group. Depression was the reason for discontinuing for 2.8 percent on the higher dose of the drug and 1.6 percent in the placebo group. Dr. Julius Gaardin, a cardiologist at Wayne State University who had no ties to the study or the company, called it and similar ones on the drug ``truly landmark studies in the field of obesity.'' He said ``the safety profile was quite good'' and obesity is such a serious problem that there ought to be higher tolerability of side effects than for drugs for other conditions. Company officials say they are on track to seek Food and Drug Administration approval within a few months. Dr. Elizabeth Nabel, director of the National Heart, Lung and Blood Institute, said health officials would welcome an effective obesity drug if it proved safe. ``The important message is that we want men and women to focus on heart-healthy behaviors, modifications in lifestyles that promote health,'' she said. Smith said the drug could give people ``a wonderful jump start,'' but that for long-term success, ``there have got to be some improved behavioral and diet changes going on beyond taking a pill.'' |
Quote:
As far as studies go - Acomplia has already undergone two 2-year studies - in North America and Europe - and the results (as Michelle posted) look very promising indeed. And as far as the comparison to Vioxx and other drugs that have been withdrawn from the market - I would presume that this would cause Sanofi to be even MORE diligent in ensuring that Acomplia, or any other new drug, is tested as rigorously as possible prior to its submission for FDA approval. Incidentally...for those of you who wish to keep track of what's happening with Acomplia - there is a website called The Acomplia Report (produced by MedicalWeek - not by Sanofi) which has been tracking the progress of the drug and is regularly updated. ;) |
| All times are GMT -4. The time now is 02:13 AM. |
Copyright © 2026 MH Sub I, LLC dba Internet Brands. All rights reserved. Use of this site indicates your consent to the Terms of Use.